Old, new and emerging functions of caspases

Cell Death and Differentiation

Volumn 22, Issue 4, 2015, Pages 526-539

  Shalini, S ^a   Dorstyn, L ^a   Dawar, S ^a   Kumar, S ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 10; CASPASE 11; CASPASE 12; CASPASE 13; CASPASE 14; CASPASE 2; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; INTERLEUKIN 1BETA CONVERTING ENZYME; AUTACOID;

AGING; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOPHAGY; CARCINOGENESIS; CELL DEATH; CELL FATE; CELL PROLIFERATION; ENZYME ACTIVATION; GENOMIC INSTABILITY; HUMAN; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE SUBPOPULATION; METABOLISM; MITOSIS; NECROPTOSIS; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; TISSUE DIFFERENTIATION; TISSUE REGENERATION; TUMOR CELL; ANIMAL; CELL DIFFERENTIATION; CHEMISTRY; REGENERATION;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CASPASES; CELL DIFFERENTIATION; GENOMIC INSTABILITY; HUMANS; INFLAMMATION MEDIATORS; REGENERATION;

EID: 84923119242     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.216     Document Type: Review

References (203)

1. Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ 2015; 22: 58-73.
2. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009; 16: 3-11.
3. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-120.
4. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C. elegans. Cell 1986; 44: 817-829.
5. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993; 75: 641-652.
6. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev 1994; 8: 1613-1626.
7. Kumar S, Tomooka Y, Noda M. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem Biophys Res Commun 1992; 185: 1155-1161.
8. Eckhart L, Ballaun C, Hermann M, VandeBerg JL, Sipos W, Uthman A et al. Identification of novel mammalian caspases reveals an important role of gene loss in shaping the human caspase repertoire. Mol Biol Evol 2008; 25: 831-841.
9. McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013; 5: a008656.
10. Fischer H, Koenig U, Eckhart L, Tschachler E. Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun 2002; 293: 722-726.
11. Hoste E, Kemperman P, Devos M, Denecker G, Kezic S, Yau N et al. Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. J Invest Dermatol 2011; 131: 2233-2241.
12. Kumar S. Caspase function in programmed cell death. Cell Death Differ 2007; 14: 32-43.
13. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014; 15: 49-63.
14. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003; 66: 1403-1408.
15. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
16. Baliga BC, Read SH, Kumar S. The biochemical mechanism of caspase-2 activation. Cell Death Differ 2004; 11: 1234-1241.
17. Butt AJ, Harvey NL, Parasivam G, Kumar S. Dimerization and autoprocessing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxyl-terminal regions. J Biol Chem 1998; 273: 6763-6768.
18. Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004; 304: 843-846.
19. Manzl C, Krumschnabel G, Bock F, Sohm B, Labi V, Baumgartner F et al. Caspase-2 activation in the absence of PIDDosome formation. J Cell Biol 2009; 185: 291-303.
20. Kumar S. Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more? Nat Rev Cancer 2009; 9: 897-903.
21. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11: 700-714.
22. Vanlangenakker N, Vanden Berghe T, Vandenabeele P. Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 2012; 19: 75-86.
23. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014; 15: 135-147.
24. Tenev T, Bianchi K, Darding M, Broemer M, Langlais C, Wallberg F et al. The ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011; 43: 432-448.
25. Ofengeim D, Yuan J. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat Rev Mol Cell Biol 2013; 14: 727-736.
26. Rickard JA, O'Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 2014; 157: 1175-1188.
27. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008; 4: 313-321.
28. Takahashi N, Vereecke L, Bertrand MJ, Duprez L, Berger SB, Divert T et al. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 2014; 513: 95-99.
29. Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 2014; 513: 90-94.
30. Monack DM, Raupach B, Hromockyj AE, Falkow S. Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc Natl Acad Sci USA 1996; 93: 9833-9838.
31. Zychlinsky A, Prevost MC, Sansonetti PJ. Shigella flexneri induces apoptosis in infected macrophages. Nature 1992; 358: 167-169.
32. Cookson BT, Brennan MA. Pro-inflammatory programmed cell death. Trends Microbiol 2001; 9: 113-114.
33. Brennan MA, Cookson BT. Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol Microbiol 2000; 38: 31-40.
34. Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev 2011; 243: 206-214.
35. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009; 7: 99-109.
36. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 2010; 11: 1136-1142.
37. Bergsbaken T, Cookson BT. Macrophage activation redirects yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog 2007; 3: e161.
38. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8: 741-752.
39. Denton D, Nicolson S, Kumar S. Cell death by autophagy: facts and apparent artefacts. Cell Death Differ 2012; 19: 87-95.
40. Cho DH, Jo YK, Hwang JJ, Lee YM, Roh SA, Kim JC. Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cells. Cancer Lett 2009; 274: 95-100.
41. Zhu Y, Zhao L, Liu L, Gao P, Tian W, Wang X et al. Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis. Protein Cell 2010; 1: 468-477.
42. Norman JM, Cohen GM, Bampton ET. The in vitro cleavage of the hAtg proteins by cell death proteases. Autophagy 2010; 6: 1042-1056.
43. Oral O, Oz-Arslan D, Itah Z, Naghavi A, Deveci R, Karacali S et al. Cleavage of Atg3 protein by caspase-8 regulates autophagy during receptor-activated cell death. Apoptosis 2012; 17: 810-820.
44. DeVorkin L, Gorski SM. A mitochondrial-associated link between an effector caspase and autophagic flux. Autophagy 2014; 10: 1866-1867.
45. Tiwari M, Sharma LK, Vanegas D, Callaway DA, Bai Y, Lechleiter JD et al. A nonapoptotic role for CASP2/caspase 2: modulation of autophagy. Autophagy 2014; 10: 1054-1070.
46. Pagliarini V, Wirawan E, Romagnoli A, Ciccosanti F, Lisi G, Lippens S et al. Proteolysis of Ambra1 during apoptosis has a role in the inhibition of the autophagic pro-survival response. Cell Death Differ 2012; 19: 1495-1504.
47. Betin VM, Lane JD. Atg4D at the interface between autophagy and apoptosis. Autophagy 2009; 5: 1057-1059.
48. Castedo M, Perfettini JL, Roumier T, Valent A, Raslova H, Yakushijin K et al. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene 2004; 23: 4362-4370.
49. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 768-774.
50. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997; 386: 619-623.
51. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995; 267: 2000-2003.
52. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995; 80: 401-411.
53. Siegmund B. Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation. Biochem Pharmacol 2002; 64: 1-8.
54. Stoven S, Silverman N, Junell A, Hedengren-Olcott M, Erturk D, Engstrom Y et al. Caspase-mediated processing of the Drosophila NF-kappaB factor Relish. Proc Natl Acad Sci USA 2003; 100: 5991-5996.
55. Tanji T, Ip YT. Regulators of the Toll and Imd pathways in the Drosophila innate immune response. Trends Immunol 2005; 26: 193-198.
56. Martinon F, Agostini L, Meylan E, Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol 2004; 14: 1929-1934.
57. Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998; 92: 501-509.
58. Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 2014; 514: 187-192.
59. Scott AM, Saleh M. The inflammatory caspases: guardians against infections and sepsis. Cell Death Differ 2007; 14: 23-31.
60. Saleh M, Mathison JC, Wolinski MK, Bensinger SJ, Fitzgerald P, Droin N et al. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 2006; 440: 1064-1068.
61. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004; 429: 75-79.
62. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417-426.
63. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004; 20: 319-325.
64. Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell 2014; 157: 1013-1022.
65. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-232.
66. Hornung V, Latz E. Intracellular DNA recognition. Nat Rev Immunol 2010; 10: 123-130.
67. Bouchier-Hayes L, Conroy H, Egan H, Adrain C, Creagh EM, MacFarlane M et al. CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways. J Biol Chem 2001; 276: 44069-44077.
68. Shimada K, Crother TR, Arditi M. Innate immune responses to Chlamydia pneumoniae infection: role of TLRs, NLRs, and the inflammasome. Microbes Infect 2012; 14: 1301-1307.
69. Allam R, Lawlor KE, Yu EC, Mildenhall AL, Moujalled DM, Lewis RS et al. Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome priming. EMBO Rep 2014; 15: 982-990.
70. Vince JE, Wong WW, Gentle I, Lawlor KE, Allam R, O'Reilly L et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 2012; 36: 215-227.
71. Maelfait J, Vercammen E, Janssens S, Schotte P, Haegman M, Magez S et al. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8. J Exp Med 2008; 205: 1967-1973.
72. Kovalenko A, Kim JC, Kang TB, Rajput A, Bogdanov K, Dittrich-Breiholz O et al. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J Exp Med 2009; 206: 2161-2177.
73. Ben Moshe T, Barash H, Kang TB, Kim JC, Kovalenko A, Gross E et al. Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology 2007; 45: 1014-1024.
74. Liedtke C, Bangen JM, Freimuth J, Beraza N, Lambertz D, Cubero FJ et al. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology 2011; 141: 2176-2187.
75. Rajput A, Kang TB, Bogdanov K, Kim JC, Ben-Moshe T, Kovalenko A et al. Anti-inflammatory functions of caspase-8. Adv Exp Med Biol 2011; 691: 253-260.
76. Lamkanfi M, Kanneganti TD, Franchi L, Nunez G. Caspase-1 inflammasomes in infection and inflammation. J Leukoc Biol 2007; 82: 220-225.
77. Mills K, Daish T, Harvey KF, Pfleger CM, Hariharan IK, Kumar S. The Drosophila melanogaster Apaf-1 homologue ARK is required for most, but not all, programmed cell death. J Cell Biol 2006; 172: 809-815.
78. Daish TJ, Mills K, Kumar S. Drosophila caspase DRONC is required for specific developmental cell death pathways and stress-induced apoptosis. Dev Cell 2004; 7: 909-915.
79. Kanuka H, Sawamoto K, Inohara N, Matsuno K, Okano H, Miura M. Control of the cell death pathway by Dapaf-1, a Drosophila Apaf-1/CED-4-related caspase activator. Mol Cell 1999; 4: 757-769.
80. Kanuka H, Kuranaga E, Takemoto K, Hiratou T, Okano H, Miura M. Drosophila caspase transduces Shaggy/GSK-3beta kinase activity in neural precursor development. EMBO J 2005; 24: 3793-3806.
81. Kuranaga E, Kanuka H, Tonoki A, Takemoto K, Tomioka T, Kobayashi M et al. Drosophila IKK-related kinase regulates nonapoptotic function of caspases via degradation of IAPs. Cell 2006; 126: 583-596.
82. Lamkanfi M, Declercq W, Vanden Berghe T, Vandenabeele P. Caspases leave the beaten track: caspase-mediated activation of NF-kappaB. J Cell Biol 2006; 173: 165-171.
83. Ishizaki Y, Jacobson MD, Raff MC. A role for caspases in lens fiber differentiation. J Cell Biol 1998; 140: 153-158.
84. Zermati Y, Garrido C, Amsellem S, Fishelson S, Bouscary D, Valensi F et al. Caspase activation is required for terminal erythroid differentiation. J Exp Med 2001; 193: 247-254.
85. Yan XX, Najbauer J, Woo CC, Dashtipour K, Ribak CE, Leon M. Expression of active caspase-3 in mitotic and postmitotic cells of the rat forebrain. J Comp Neurol 2001; 433: 4-22.
86. Fan W, Dai Y, Xu H, Zhu X, Cai P, Wang L et al. Caspase-3 modulates regenerative response after stroke. Stem Cells 2014; 32: 473-486.
87. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA. Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci USA 2002; 99: 11025-11030.
88. Murray TV, McMahon JM, Howley BA, Stanley A, Ritter T, Mohr A et al. A non-apoptotic role for caspase-9 in muscle differentiation. J Cell Sci 2008; 121: 3786-3793.
89. Miura M, Chen XD, Allen MR, Bi Y, Gronthos S, Seo BM et al. A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest 2004; 114: 1704-1713.
90. Mogi M, Togari A. Activation of caspases is required for osteoblastic differentiation. J Biol Chem 2003; 278: 47477-47482.
91. Matalova E, Lesot H, Svandova E, Vanden Berghe T, Sharpe PT, Healy C et al. Caspase-7 participates in differentiation of cells forming dental hard tissues. Dev Growth Differ 2013; 55: 615-621.
92. Fujita J, Crane AM, Souza MK, Dejosez M, Kyba M, Flavell RA et al. Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2008; 2: 595-601.
93. Janzen V, Fleming HE, Riedt T, Karlsson G, Riese MJ, Lo Celso C et al. Hematopoietic stem cell responsiveness to exogenous signals is limited by caspase-3. Cell Stem Cell 2008; 2: 584-594.
94. Sordet O, Rebe C, Plenchette S, Zermati Y, Hermine O, Vainchenker W et al. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 2002; 100: 4446-4453.
95. Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 2004; 173: 2976-2984.
96. Rebe C, Cathelin S, Launay S, Filomenko R, Prevotat L, L'Ollivier C et al. Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood 2007; 109: 1442-1450.
97. Lamkanfi M, Declercq W, Kalai M, Saelens X, Vandenabeele P. Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ 2002; 9: 358-361.
98. Eckhart L, Declercq W, Ban J, Rendl M, Lengauer B, Mayer C et al. Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation. J Invest Dermatol 2000; 115: 1148-1151.
99. Lippens S, Kockx M, Knaapen M, Mortier L, Polakowska R, Verheyen A et al. Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ 2000; 7: 1218-1224.
100. Rendl M, Ban J, Mrass P, Mayer C, Lengauer B, Eckhart L et al. Caspase-14 expression by epidermal keratinocytes is regulated by retinoids in a differentiation-associated manner. J Invest Dermatol 2002; 119: 1150-1155.
101. Denecker G, Hoste E, Gilbert B, Hochepied T, Ovaere P, Lippens S et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 2007; 9: 666-674.
102. Okuyama R, Nguyen BC, Talora C, Ogawa E, Tommasi di Vignano A, Lioumi M et al. High commitment of embryonic keratinocytes to terminal differentiation through a Notch1-caspase 3 regulatory mechanism. Dev Cell 2004; 6: 551-562.
103. Hsu S, Dickinson D, Borke J, Walsh DS, Wood J, Qin H et al. Green tea polyphenol induces caspase 14 in epidermal keratinocytes via MAPK pathways and reduces psoriasiform lesions in the flaky skin mouse model. Exp Dermatol 2007; 16: 678-684.
104. Chera S, Ghila L, Dobretz K, Wenger Y, Bauer C, Buzgariu W et al. Apoptotic cells provide an unexpected source of Wnt3 signaling to drive hydra head regeneration. Dev Cell 2009; 17: 279-289.
105. Tseng AS, Adams DS, Qiu D, Koustubhan P, Levin M. Apoptosis is required during early stages of tail regeneration in Xenopus laevis. Dev Biol 2007; 301: 62-69.
106. Fan Y, Bergmann A. Distinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye. Dev Cell 2008; 14: 399-410.
107. Milan M, Campuzano S, Garcia-Bellido A. Developmental parameters of cell death in the wing disc of Drosophila. Proc Natl Acad Sci USA 1997; 94: 5691-5696.
108. Wells BS, Yoshida E, Johnston LA. Compensatory proliferation in Drosophila imaginal discs requires Dronc-dependent p53 activity. Curr Biol 2006; 16: 1606-1615.
109. Kondo S, Senoo-Matsuda N, Hiromi Y, Miura M. DRONC coordinates cell death and compensatory proliferation. Mol Cell Biol 2006; 26: 7258-7268.
110. Huh JR, Guo M, Hay BA. Compensatory proliferation induced by cell death in the Drosophila wing disc requires activity of the apical cell death caspase Dronc in a nonapoptotic role. Curr Biol 2004; 14: 1262-1266.
111. Li F, Huang Q, Chen J, Peng Y, Roop DR, Bedford JS et al. Apoptotic cells activate the 'phoenix rising' pathway to promote wound healing and tissue regeneration. Sci Signal 2010; 3: ra13.
112. Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009; 136: 1136-1147.
113. Freimuth J, Bangen JM, Lambertz D, Hu W, Nevzorova YA, Sonntag R et al. Loss of caspase-8 in hepatocytes accelerates the onset of liver regeneration in mice through premature nuclear factor kappa B activation. Hepatology 2013; 58: 1779-1789.
114. Svandova E, Lesot H, Vanden Berghe T, Tucker AS, Sharpe PT, Vandenabeele P et al. Non-apoptotic functions of caspase-7 during osteogenesis. Cell Death Dis 2014; 5: e1366.
115. Alam A, Cohen LY, Aouad S, Sekaly RP. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med 1999; 190: 1879-1890.
116. Kennedy NJ, Kataoka T, Tschopp J, Budd RC. Caspase activation is required for T cell proliferation. J Exp Med 1999; 190: 1891-1896.
117. Lens SM, Kataoka T, Fortner KA, Tinel A, Ferrero I, MacDonald RH et al. The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol 2002; 22: 5419-5433.
118. Salmena L, Lemmers B, Hakem A, Matysiak-Zablocki E, Murakami K, Au PY et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17: 883-895.
119. Salmena L, Hakem R. Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder. J Exp Med 2005; 202: 727-732.
120. Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002; 419: 395-399.
121. Pellegrini M, Bath S, Marsden VS, Huang DC, Metcalf D, Harris AW et al. FADD and caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cells. Blood 2005; 106: 1581-1589.
122. Gilot D, Serandour AL, Ilyin GP, Lagadic-Gossmann D, Loyer P, Corlu A et al. A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes. Carcinogenesis 2005; 26: 2086-2094.
123. Beisner DR, Ch'en IL, Kolla RV, Hoffmann A, Hedrick SM. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J Immunol 2005; 175: 3469-3473.
124. Olson NE, Graves JD, Shu GL, Ryan EJ, Clark EA. Caspase activity is required for stimulated B lymphocytes to enter the cell cycle. J Immunol 2003; 170: 6065-6072.
125. Woo M, Hakem R, Furlonger C, Hakem A, Duncan GS, Sasaki T et al. Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. Nat Immunol 2003; 4: 1016-1022.
126. Frost V, Al-Mehairi S, Sinclair AJ. Exploitation of a non-apoptotic caspase to regulate the abundance of the cdkI p27(KIP1) in transformed lymphoid cells. Oncogene 2001; 20: 2737-2748.
127. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-1443.
128. Monni O, Joensuu H, Franssila K, Klefstrom J, Alitalo K, Knuutila S. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood 1997; 90: 1168-1174.
129. Hunter AM, LaCasse EC, Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 2007; 12: 1543-1568.
130. Jager R, Zwacka RM. The enigmatic roles of caspases in tumor development. Cancers (Basel) 2010; 2: 1952-1979.
131. Winter RN, Rhee JG, Kyprianou N. Caspase-1 enhances the apoptotic response of prostate cancer cells to ionizing radiation. Anticancer Res 2004; 24: 1377-1386.
132. Ummanni R, Lehnigk U, Zimmermann U, Woenckhaus C, Walther R, Giebel J. Immunohistochemical expression of caspase-1 and -9, uncleaved caspase-3 and -6, cleaved caspase-3 and -6 as well as Bcl-2 in benign epithelium and cancer of the prostate. Exp Ther Med 2010; 1: 47-52.
133. Winter RN, Kramer A, Borkowski A, Kyprianou N. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 2001; 61: 1227-1232.
134. Ueki T, Takeuchi T, Nishimatsu H, Kajiwara T, Moriyama N, Narita Y et al. Silencing of the caspase-1 gene occurs in murine and human renal cancer cells and causes solid tumor growth in vivo. Int J Cancer 2001; 91: 673-679.
135. Hu B, Elinav E, Huber S, Booth CJ, Strowig T, Jin C et al. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci USA 2010; 107: 21635-21640.
136. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J et al. Non-canonical inflammasome activation targets caspase-11. Nature 2011; 479: 117-121.
137. Kumar S, White DL, Takai S, Turczynowicz S, Juttner CA, Hughes TP. Apoptosis regulatory gene NEDD2 maps to human chromosome segment 7q34-35, a region frequently affected in haematological neoplasms. Hum Genet 1995; 95: 641-644.
138. Kim MS, Chung NG, Yoo NJ, Lee SH. Somatic mutation of proapoptotic caspase-2 gene is rare in acute leukemias and common solid cancers. Eur J Haematol 2011; 86: 449-450.
139. Hofmann WK, de Vos S, Tsukasaki K, Wachsman W, Pinkus GS, Said JW et al. Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood 2001; 98: 787-794.
140. Holleman A, den Boer ML, Kazemier KM, Beverloo HB, von Bergh AR, Janka-Schaub GE et al. Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Blood 2005; 106: 1817-1823.
141. Estrov Z, Thall PF, Talpaz M, Estey EH, Kantarjian HM, Andreeff M et al. Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia. Blood 1998; 92: 3090-3097.
142. Yoo NJ, Lee JW, Kim YJ, Soung YH, Kim SY, Nam SW et al. Loss of caspase-2, -6 and -7 expression in gastric cancers. APMIS 2004; 112: 330-335.
143. Ho LH, Taylor R, Dorstyn L, Cakouros D, Bouillet P, Kumar S. A tumor suppressor function for caspase-2. Proc Natl Acad Sci USA 2009; 106: 5336-5341.
144. Parsons MJ, McCormick L, Janke L, Howard A, Bouchier-Hayes L, Green DR. Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice. Cell Death Differ 2013; 20: 1174-1182.
145. Puccini J, Shalini S, Voss AK, Gatei M, Wilson CH, Hiwase DK et al. Loss of caspase-2 augments lymphomagenesis and enhances genomic instability in Atm-deficient mice. Proc Natl Acad Sci USA 2013; 110: 19920-19925.
146. Manzl C, Fava LL, Krumschnabel G, Peintner L, Tanzer MC, Soratroi C et al. Death of p53-defective cells triggered by forced mitotic entry in the presence of DNA damage is not uniquely dependent on Caspase-2 or the PIDDosome. Cell Death Dis 2013; 4: e942.
147. Dorstyn L, Puccini J, Wilson CH, Shalini S, Nicola M, Moore S et al. Caspase-2 deficiency promotes aberrant DNA-damage response and genetic instability. Cell Death Differ 2012; 19: 1288-1298.
148. Terry MR, Arya R, Mukhopadhyay A, Berrett KC, Clair PM, Witt B et al. Caspase-2 impacts lung tumorigenesis and chemotherapy response in vivo. Cell Death Differ 2014; e-pub ahead of print 10 October 2014; doi:10.1038/cdd.2014.159.
149. Manzl C, Peintner L, Krumschnabel G, Bock F, Labi V, Drach M et al. PIDDosome-independent tumor suppression by caspase-2. Cell Death Differ 2012; 19: 1722-1732.
150. Dorstyn L, Puccini J, Nikolic A, Shalini S, Wilson CH, Norris MD et al. An unexpected role for caspase-2 in neuroblastoma. Cell Death Dis 2014; 5: e1383.
151. Yan S, Li YZ, Zhu XW, Liu CL, Wang P, Liu YL. HuGE systematic review and meta-analysis demonstrate association of CASP-3 and CASP-7 genetic polymorphisms with cancer risk. Genet Mol Res 2013; 12: 1561-1573.
152. Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY et al. Somatic mutations of CASP3 gene in human cancers. Hum Genet 2004; 115: 112-115.
153. Chen K, Zhao H, Hu Z, Wang LE, Zhang W, Sturgis EM et al. CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck. Clin Cancer Res 2008; 14: 6343-6349.
154. Xu HL, Xu WH, Cai Q, Feng M, Long J, Zheng W et al. Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev 2009; 18: 2114-2122.
155. Lan Q, Morton LM, Armstrong B, Hartge P, Menashe I, Zheng T et al. Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood 2009; 114: 264-267.
156. Hosgood HD 3rd, Baris D, Zhang Y, Zhu Y, Zheng T, Yeager M et al. Caspase polymorphisms and genetic susceptibility to multiple myeloma. Hematol Oncol 2008; 26: 148-151.
157. Jang JS, Kim KM, Choi JE, Cha SI, Kim CH, Lee WK et al. Identification of polymorphisms in the caspase-3 gene and their association with lung cancer risk. Mol Carcinog 2008; 47: 383-390.
158. Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, Brun AM et al. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 2002; 21: 8843-8851.
159. O'Donovan N, Crown J, Stunell H, Hill AD, McDermott E, O'Higgins N et al. Caspase 3 in breast cancer. Clin Cancer Res 2003; 9: 738-742.
160. Huang Q, Li F, Liu X, Li W, Shi W, Liu FF et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 2011; 17: 860-866.
161. Soung YH, Lee JW, Kim HS, Park WS, Kim SY, Lee JH et al. Inactivating mutations of CASPASE-7 gene in human cancers. Oncogene 2003; 22: 8048-8052.
162. Lee WK, Kim JS, Kang HG, Cha SI, Kim DS, Hyun DS et al. Polymorphisms in the Caspase7 gene and the risk of lung cancer. Lung Cancer 2009; 65: 19-24.
163. Ponten F, Jirstrom K, Uhlen M. The Human Protein Atlas - a tool for pathology. J Pathol 2008; 216: 387-393.
164. Kim HS, Lee JW, Soung YH, Park WS, Kim SY, Lee JH et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003; 125: 708-715.
165. Soung YH, Lee JW, Kim SY, Sung YJ, Park WS, Nam SW et al. Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225-1226delTG in hepatocellular carcinomas. Oncogene 2005; 24: 141-147.
166. Soung YH, Lee JW, Kim SY, Jang J, Park YG, Park WS et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 2005; 65: 815-821.
167. MacPherson G, Healey CS, Teare MD, Balasubramanian SP, Reed MW, Pharoah PD et al. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 2004; 96: 1866-1869.
168. Teitz T, Lahti JM, Kidd VJ. Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death. J Mol Med (Berl) 2001; 79: 428-436.
169. Grotzer MA, Eggert A, Zuzak TJ, Janss AJ, Marwaha S, Wiewrodt BR et al. Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression. Oncogene 2000; 19: 4604-4610.
170. Ebinger M, Senf L, Wachowski O, Scheurlen W. Promoter methylation pattern of caspase-8, P16INK4A, MGMT, TIMP-3, and E-cadherin in medulloblastoma. Pathol Oncol Res 2004; 10: 17-21.
171. Martinez R, Setien F, Voelter C, Casado S, Quesada MP, Schackert G et al. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis 2007; 28: 1264-1268.
172. Shivapurkar N, Toyooka S, Eby MT, Huang CX, Sathyanarayana UG, Cunningham HT et al. Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther 2002; 1: 65-69.
173. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000; 6: 529-535.
174. Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, Kidd VJ et al. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 2006; 439: 95-99.
175. Teitz T, Inoue M, Valentine MB, Zhu K, Rehg JE, Zhao W et al. Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis. Cancer Res 2013; 73: 4086-4097.
176. Stupack DG. Caspase-8 as a therapeutic target in cancer. Cancer Lett 2013; 332: 133-140.
177. Graf RP, Keller N, Barbero S, Stupack D. Caspase-8 as a regulator of tumor cell motility. Curr Mol Med 2014; 14: 246-254.
178. Shin MS, Kim HS, Kang CS, Park WS, Kim SY, Lee SN et al. Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 2002; 99: 4094-4099.
179. Kim MS, Oh JE, Min CK, Lee S, Chung NG, Yoo NJ et al. Mutational analysis of CASP10 gene in acute leukaemias and multiple myelomas. Pathology 2009; 41: 484-487.
180. Oh JE, Kim MS, Ahn CH, Kim SS, Han JY, Lee SH et al. Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas. Pathology 2010; 42: 73-76.
181. Park WS, Lee JH, Shin MS, Park JY, Kim HS, Lee JH et al. Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 2002; 21: 2919-2925.
182. Lamy L, Ngo VN, Emre NC, Shaffer AL 3rd, Yang Y, Tian E et al. Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell 2013; 23: 435-449.
183. Krajewska M, Kim H, Shin E, Kennedy S, Duffy MJ, Wong YF et al. Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin Cancer Res 2005; 11: 5462-5471.
184. Wu M, Kodani I, Dickinson D, Huff F, Ogbureke KU, Qin H et al. Exogenous expression of caspase-14 induces tumor suppression in human salivary cancer cells by inhibiting tumor vascularization. Anticancer Res 2009; 29: 3811-3818.
185. Dinarello CA. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 2006; 83: 447S-455S.
186. Salminen A, Kaarniranta K, Kauppinen A. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) 2012; 4: 166-175.
187. Gemma C, Fister M, Hudson C, Bickford PC. Improvement of memory for context by inhibition of caspase-1 in aged rats. Eur J Neurosci 2005; 22: 1751-1756.
188. LeBlanc AC. Caspase-6 as a novel early target in the treatment of Alzheimer's disease. Eur J Neurosci 2013; 37: 2005-2018.
189. Fulle S, Sancilio S, Mancinelli R, Gatta V, Di Pietro R. Dual role of the caspase enzymes in satellite cells from aged and young subjects. Cell Death Dis 2013; 4: e955.
190. Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010; 143: 802-812.
191. Seidman MD, Khan MJ, Bai U, Shirwany N, Quirk WS. Biologic activity of mitochondrial metabolites on aging and age-related hearing loss. Am J Otol 2000; 21: 161-167.
192. Naidoo N, Ferber M, Master M, Zhu Y, Pack AI. Aging impairs the unfolded protein response to sleep deprivation and leads to proapoptotic signaling. J Neurosci 2008; 28: 6539-6548.
193. Zhang Y, Padalecki SS, Chaudhuri AR, De Waal E, Goins BA, Grubbs B et al. Caspase-2 deficiency enhances aging-related traits in mice. Mech Ageing Dev 2007; 128: 213-221.
194. Shalini S, Dorstyn L, Wilson C, Puccini J, Ho L, Kumar S. Impaired antioxidant defence and accumulation of oxidative stress in caspase-2-deficient mice. Cell Death Differ 2012; 19: 1370-1380.
195. Shalini S, Puccini J, Wilson CH, Finnie J, Dorstyn L, Kumar S. Caspase-2 protects against oxidative stress in vivo. Oncogene 2014; doi:10.1038/onc.2014.413.
196. Lopez-Cruzan M, Herman B. Loss of caspase-2 accelerates age-dependent alterations in mitochondrial production of reactive oxygen species. Biogerontology 2013; 14: 121-130.
197. Hyman BT, Yuan J. Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology. Nat Rev Neurosci 2012; 13: 395-406.
198. Kuo CT, Zhu S, Younger S, Jan LY, Jan YN. Identification of E2/E3 ubiquitinating enzymes and caspase activity regulating Drosophila sensory neuron dendrite pruning. Neuron 2006; 51: 283-290.
199. Erturk A, Wang Y, Sheng M. Local pruning of dendrites and spines by caspase-3-dependent and proteasome-limited mechanisms. J Neurosci 2014; 34: 1672-1688.
200. Pozueta J, Lefort R, Ribe EM, Troy CM, Arancio O, Shelanski M. Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice. Nat Commun 2013; 4: 1939.
201. Ohsawa S, Hamada S, Kuida K, Yoshida H, Igaki T, Miura M. Maturation of the olfactory sensory neurons by Apaf-1/caspase-9-mediated caspase activity. Proc Natl Acad Sci USA 2010; 107: 13366-13371.
202. Simon DJ, Weimer RM, McLaughlin T, Kallop D, Stanger K, Yang J et al. A caspase cascade regulating developmental axon degeneration. J Neurosci 2012; 32: 17540-17553.
203. Li Z, Jo J, Jia JM, Lo SC, Whitcomb DJ, Jiao S et al. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 2010; 141: 859-871.